Cimetidine versus intensive antacid therapy for duodenal ulcer: a multicenter trial.

作者: A.F. Ippoliti , R.A.L. Sturdevant , J.I. Isenberg , M. Binder , R. Camacho

DOI: 10.1016/0016-5085(78)90768-0

关键词:

摘要: Abstract In a randomized double blind multicenter trial, patients treated with cimetidine (800 or 1200 mg daily) an intensive regimen of Al-Mg antacid (210 ml had similar rates duodenal ulcer healing and pain relief. After 4 weeks treatment, the proportion by endoscopy were: (1200 mg), 21 33 (64%); 19 32 (59%); antacids, 15 29 (52%). These proportions did not differ significantly. Eighty per cent cimetidine-treated became asymptomatic week 4, as 63% antacid-treated ( P > 0.1). No untoward effects were observed during treatment. Twenty-seven reported diarrhea.

参考文章(7)
Walter L. Peterson, Richard A. L. Sturdevant, Harold D. Frankl, Charles T. Richardson, Jon I. Isenberg, Janet D. Elashoff, James Q. Sones, Robert A. Gross, Richard W. McCallum, John S. Fordtran, Healing of Duodenal Ulcer with an Antacid Regimen The New England Journal of Medicine. ,vol. 297, pp. 341- 345 ,(1977) , 10.1056/NEJM197708182970701
G. Bodemar, A. Walan, Cimetidine in the treatment of active duodenal and prepyloric ulcers. The Lancet. ,vol. 308, pp. 161- 164 ,(1976) , 10.1016/S0140-6736(76)92342-4
W.S. Blackwood, R.G. Pickard, D.P. Maudgal, D. Lawrence, T.C. Northfield, CIMETIDINE IN DUODENAL ULCER Controlled Trial The Lancet. ,vol. 308, pp. 174- 176 ,(1976) , 10.1016/S0140-6736(76)92347-3
G.R. Gray, I.S. Smith, I. Mckenzie, G.P. Crean, G. Gillespie, ORAL CIMETIDINE IN SEVERE DUODENAL ULCERATION: A Double-blind Controlled Trial The Lancet. ,vol. 309, pp. 4- 7 ,(1977) , 10.1016/S0140-6736(77)91650-6
John S. Fordtran, Stephen G. Morawski, Charles T. Richardson, In Vivo and in Vitro Evaluation of Liquid Antacids New England Journal of Medicine. ,vol. 288, pp. 923- 928 ,(1973) , 10.1056/NEJM197305032881801
George W. Snedecor, Statistical methods ,(1967)